BALPHARMA.BOBALPHARMA.BOBSE
Loading
Cost of Revenue Over TimeContracting
Percentile Rank87
3Y CAGR+5.3%
5Y CAGR+5.9%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+5.3%/yr
vs +9.5%/yr prior
5Y CAGR
+5.9%/yr
Consistent
Acceleration
-4.1pp
Decelerating
Percentile
P87
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $2.02B | -16.9% |
| 2025 | $2.43B | -7.4% |
| 2024 | $2.62B | +51.8% |
| 2023 | $1.73B | +1.8% |
| 2022 | $1.70B | +12.2% |
| 2021 | $1.51B | +76.7% |
| 2020 | $856.04M | -28.9% |
| 2019 | $1.20B | +17.8% |
| 2018 | $1.02B | -12.7% |
| 2017 | $1.17B | - |